260 related articles for article (PubMed ID: 18515091)
1. The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease.
Miele L; Beale G; Patman G; Nobili V; Leathart J; Grieco A; Abate M; Friedman SL; Narla G; Bugianesi E; Day CP; Reeves HL
Gastroenterology; 2008 Jul; 135(1):282-291.e1. PubMed ID: 18515091
[TBL] [Abstract][Full Text] [Related]
2. Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease.
Bechmann LP; Gastaldelli A; Vetter D; Patman GL; Pascoe L; Hannivoort RA; Lee UE; Fiel I; Muñoz U; Ciociaro D; Lee YM; Buzzigoli E; Miele L; Hui KY; Bugianesi E; Burt AD; Day CP; Mari A; Agius L; Walker M; Friedman SL; Reeves HL
Hepatology; 2012 Apr; 55(4):1083-93. PubMed ID: 22095588
[TBL] [Abstract][Full Text] [Related]
3. KLF6 in nonalcoholic fatty liver disease: role of fibrogenesis and carcinogenesis.
Watanabe K; Ohnishi S; Manabe I; Nagai R; Kadowaki T
Gastroenterology; 2008 Jul; 135(1):309-12. PubMed ID: 18558090
[No Abstract] [Full Text] [Related]
4. Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma.
Yea S; Narla G; Zhao X; Garg R; Tal-Kremer S; Hod E; Villanueva A; Loke J; Tarocchi M; Akita K; Shirasawa S; Sasazuki T; Martignetti JA; Llovet JM; Friedman SL
Gastroenterology; 2008 May; 134(5):1521-31. PubMed ID: 18471523
[TBL] [Abstract][Full Text] [Related]
5. Kruppel-like factor 6 suppresses growth and invasion of hepatocellular carcinoma cells in vitro and in vivo.
Wen PH; Wang DY; Zhang JK; Wang ZH; Pan J; Shi XY; Yang H; Zhang SJ; Guo WZ
Int J Immunopathol Pharmacol; 2016 Dec; 29(4):666-675. PubMed ID: 27510817
[TBL] [Abstract][Full Text] [Related]
6. Post-transcriptional activation of PPAR alpha by KLF6 in hepatic steatosis.
Bechmann LP; Vetter D; Ishida J; Hannivoort RA; Lang UE; Kocabayoglu P; Fiel MI; Muñoz U; Patman GL; Ge F; Yakar S; Li X; Agius L; Lee YM; Zhang W; Hui KY; Televantou D; Schwartz GJ; LeRoith D; Berk PD; Nagai R; Suzuki T; Reeves HL; Friedman SL
J Hepatol; 2013 May; 58(5):1000-6. PubMed ID: 23353867
[TBL] [Abstract][Full Text] [Related]
7. Enhanced hepatocarcinogenesis in mouse models and human hepatocellular carcinoma by coordinate KLF6 depletion and increased messenger RNA splicing.
Vetter D; Cohen-Naftaly M; Villanueva A; Lee YA; Kocabayoglu P; Hannivoort R; Narla G; M Llovet J; Thung SN; Friedman SL
Hepatology; 2012 Oct; 56(4):1361-70. PubMed ID: 22535637
[TBL] [Abstract][Full Text] [Related]
8. New candidate tumor-suppressor gene KLF6 and its splice variant KLF6 SV2 counterbalancing expression in primary hepatocarcinoma.
Zhenzhen Z; De'an T; Limin X; Wei Y; Min L
Hepatogastroenterology; 2012; 59(114):473-6. PubMed ID: 21940380
[TBL] [Abstract][Full Text] [Related]
9. In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma.
Narla G; Kremer-Tal S; Matsumoto N; Zhao X; Yao S; Kelley K; Tarocchi M; Friedman SL
Oncogene; 2007 Jun; 26(30):4428-34. PubMed ID: 17297474
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1.
Muñoz Ú; Puche JE; Hannivoort R; Lang UE; Cohen-Naftaly M; Friedman SL
Mol Cancer Res; 2012 Sep; 10(9):1216-27. PubMed ID: 22859706
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of the tumor suppressor Krüppel-like factor 6 (KLF6) by mutation or decreased expression in hepatocellular carcinomas.
Pan XC; Chen Z; Chen F; Chen XH; Jin HY; Xu XY
J Zhejiang Univ Sci B; 2006 Oct; 7(10):830-6. PubMed ID: 16972326
[TBL] [Abstract][Full Text] [Related]
12. Frequent down-regulation and deletion of KLF6 in primary hepatocellular carcinoma.
Wang S; Kang L; Chen X; Zhou H
J Huazhong Univ Sci Technolog Med Sci; 2010 Aug; 30(4):470-6. PubMed ID: 20714872
[TBL] [Abstract][Full Text] [Related]
13. [Mutations of the tumor suppressor Kruppel-like factor 6 (KLF6) gene in hepatocellular carcinoma and its effect of growth suppression on human hepatocellular carcinoma cell line HepG2].
Pan XC; Chen Z; Chen F; Chen XH; Zhou C; Yang ZG
Zhonghua Gan Zang Bing Za Zhi; 2006 Feb; 14(2):109-13. PubMed ID: 16494780
[TBL] [Abstract][Full Text] [Related]
14. Identification of miRNAs that specifically target tumor suppressive KLF6-FL rather than oncogenic KLF6-SV1 isoform.
Liang WC; Wang Y; Xiao LJ; Wang YB; Fu WM; Wang WM; Jiang HQ; Qi W; Wan DC; Zhang JF; Waye MM
RNA Biol; 2014; 11(7):845-54. PubMed ID: 24921656
[TBL] [Abstract][Full Text] [Related]
15. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
[TBL] [Abstract][Full Text] [Related]
16. Expression of the transcription factor Klf6 in cirrhosis, macronodules, and hepatocellular carcinoma.
Bureau C; Péron JM; Bouisson M; Danjoux M; Selves J; Bioulac-Sage P; Balabaud C; Torrisani J; Cordelier P; Buscail L; Vinel JP
J Gastroenterol Hepatol; 2008 Jan; 23(1):78-86. PubMed ID: 18171345
[TBL] [Abstract][Full Text] [Related]
17. Krüppel-like factor 5 as potential molecular marker in cervical cancer and the KLF family profile expression.
Marrero-Rodríguez D; Taniguchi-Ponciano K; Jimenez-Vega F; Romero-Morelos P; Mendoza-Rodríguez M; Mantilla A; Rodriguez-Esquivel M; Hernandez D; Hernandez A; Gomez-Gutierrez G; Muñoz-Hernandez N; la Cruz HA; Vargas-Requena C; Díaz-Hernández C; Serna-Reyna L; Meraz-Rios M; Bandala C; Ortiz-Leon J; Salcedo M
Tumour Biol; 2014 Nov; 35(11):11399-407. PubMed ID: 25119587
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress, KLF6 and transforming growth factor-beta up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats.
Stärkel P; Sempoux C; Leclercq I; Herin M; Deby C; Desager JP; Horsmans Y
J Hepatol; 2003 Oct; 39(4):538-46. PubMed ID: 12971963
[TBL] [Abstract][Full Text] [Related]
19. The Krüppel-like factor 6 genotype is associated with gastric cancer in a Chinese population.
Chen H; Chen L; Zhang QF
J Int Med Res; 2010; 38(5):1801-7. PubMed ID: 21309496
[TBL] [Abstract][Full Text] [Related]
20. KLF6 IVS1 -27G/A polymorphism with susceptibility to gastric cancers in Korean.
Cho YG; Lee HS; Song JH; Kim CJ; Park YK; Nam SW; Yoo NJ; Lee JY; Park WS
Neoplasma; 2008; 55(1):47-50. PubMed ID: 18190240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
